Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cell vaccination in multiple sclerosis

I Zhang1, J Raus

  • 1Dr L Willems Instituut, Diepenbeek, Belgium.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|July 1, 1996
PubMed
Summary

T cell vaccination using inactivated myelin basic protein (MBP) autoreactive T cells shows potential for treating multiple sclerosis (MS). This therapy induces a specific immune response that reduces clinical exacerbations and brain lesions in MS patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of Soluble Interleukin 2 Receptor in Sera of Adult Patients with Hematological or Solid Malignancies.

Leukemia & lymphoma·2016
Same author

Postdexamethason intact and multisequentia ACTH in melancholia.

Acta neuropsychiatrica·2016
Same author

[Reactive oxygen species are triggers and mediators of an increase in cardiac tolerance to impact of ischemia-reperfusion].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova·2015
Same author

[Problem of end-effector of ischemic postconditioning of the heart].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova·2014
Same author

[Receptor and signalling mechanisms of antiarrhythmic effects of ischemic pre-conditioning].

Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova·2013
Same author

[Role of heat shock proteins in the mechanism of cardioprotective effect of transient hyperthermia and delayed preconditioning].

Patologicheskaia fiziologiia i eksperimental'naia terapiia·2012

Area of Science:

  • Neuroimmunology
  • Autoimmune Diseases
  • Clinical Immunology

Background:

  • T cell responses to myelin basic protein (MBP) are central to multiple sclerosis (MS) pathogenesis.
  • Autoreactive T cells accumulate in the brain lesions of MS patients, driving inflammation.

Purpose of the Study:

  • To evaluate the therapeutic potential of T cell vaccination in treating multiple sclerosis (MS).
  • To assess the immunological and clinical effects of T cell vaccination in MS patients.

Main Methods:

  • Phase one clinical trial involving T cell vaccination with inactivated MBP autoreactive T cells.
  • Longitudinal clinical evaluation and magnetic resonance imaging (MRI) to assess disease progression.

Main Results:

  • T cell vaccination induced a clonotype-specific, long-lasting regulatory T cell network.
  • Vaccinated MS patients showed a moderate reduction in clinical exacerbations, disability, and brain lesions compared to controls.

Conclusions:

  • T cell vaccination demonstrates promise as a specific immunotherapy for multiple sclerosis.
  • Further research is warranted to optimize T cell vaccination for clinical application in MS treatment.

Related Experiment Videos